GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 678.00
Bid: 677.50
Ask: 678.50
Change: -5.50 (-0.80%)
Spread: 1.00 (0.148%)
Open: 679.00
High: 684.00
Low: 675.00
Prev. Close: 683.50
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

28 Mar 2013 07:00

28 March 2013 – Tate & Lyle PLC

STATEMENT ON ENTERING CLOSE PERIOD

In line with our usual practice, Tate & Lyle PLC issues the following update for the year ending 31 March 2013 ahead of the announcement of the full year results on 30 May 2013.

Since the interim management statement in February, the Group has continued to perform solidly and in line with our expectations. We continue to expect to deliver modest progress for the full financial year.

FULL YEAR OPERATING PERFORMANCE – CONTINUING OPERATIONS

In Speciality Food Ingredients, we will achieve solid sales growth for the full year with the rate of volume growth in the second half slightly ahead of that achieved during the first half. While sucralose volume growth has continued at more normal run rates in the fourth quarter, volumes for the full year, as anticipated, will be slightly lower than the prior year. Operating profit in this division will be broadly in line with last year as a result of the step change in fixed costs associated with our business transformation initiatives.1

Within Bulk Ingredients, a good underlying performance from sweeteners in both the US and Europe is expected to more than offset the impact of the costs associated with handling higher levels of aflatoxin2 following the severe drought in the US in 2012 and continued challenging market conditions in US ethanol.

BALANCE SHEET

The recent strengthening of the US dollar against sterling will result in net debt being somewhat higher than previously anticipated due to the translation of US dollar denominated debt. As a result, net debt at 31 March 2013 is now expected to be slightly higher than the level reported at the end of last year.

Note 1 Restart of the McIntosh facility; investment in global shared services and IS/IT system; development of global Commercial and Food Innovation Centre in Chicago

Note 2 A fungus impacting corn quality caused by extremely dry and hot conditions

END

A conference call will be held today at 8.00am GMT, hosted by Javed Ahmed, Chief Executive and Tim Lodge, Chief Financial Officer.

Participants are able to pre-register for the call using the following link: http://emea.directeventreg.com/registration/26924714 .

Participants who have not pre-registered are able to access the live call by using the dial in details below. We would recommend that participants who have not pre-registered dial in at least 10 minutes before the commencement of the call.

Dial in details:UK dial in number: +44 (0) 1452 582 725Conference ID: 26924714

There is also a 14 day conference call replay facility.

Replay dial in details:UK replay number: +44 (0)1452 550 000Replay Access code: 26924714

For more information contact Tate & Lyle PLC:

Mathew Wootton, Group VP, Investor and Media RelationsTel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7500 100 320

Andrew Lorenz, FTI ConsultingTel: +44 (0) 20 7269 7113 or Mobile: +44 (0) 7775 641 807

Copyright Business Wire 2013

Date   Source Headline
10th Aug 20222:15 pmRNSDirector/PDMR Shareholding
4th Aug 20223:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20224:00 pmRNSHolding(s) in Company
28th Jul 20221:00 pmRNSUpdate on Preference Share Reduction Timetable
28th Jul 202212:45 pmRNSResult of AGM
15th Jul 20225:20 pmRNSDirector/PDMR Shareholding
1st Jul 202210:45 amRNSBlock listing Interim Review
1st Jul 202210:17 amRNSTotal Voting Rights
29th Jun 20224:25 pmRNSDirector/PDMR Shareholding
29th Jun 20224:00 pmRNSDirector/PDMR Shareholding
24th Jun 20224:15 pmRNSHolding(s) in Company
23rd Jun 20223:00 pmRNSHolding(s) in Company
21st Jun 20222:30 pmRNSAnnual Financial Report and Notice of Meeting 2022
17th Jun 20222:00 pmRNSHolding(s) in Company
15th Jun 20222:00 pmRNSHolding(s) in Company
15th Jun 20227:00 amRNSProposed Cancellation&Repayment Preference Shares
10th Jun 20222:00 pmRNSHolding(s) in Company
9th Jun 20227:06 amRNSAcquisition
9th Jun 20227:00 amRNSFinal Results
19th May 20225:00 pmRNSDirector/PDMR Shareholding
9th May 20222:23 pmRNSHolding(s) in Company
6th May 20222:46 pmRNSHolding(s) in Company
3rd May 20225:45 pmRNSHolding(s) in Company
3rd May 20228:01 amRNSShare Consolidation Effective Total Voting Rights
29th Apr 20223:15 pmRNSListing and Trading Application
26th Apr 20224:00 pmRNSResult of Meeting
13th Apr 20222:00 pmRNSHolding(s) in Company
7th Apr 20225:30 pmRNSHolding(s) in Company
7th Apr 202211:00 amRNSCirc re. special dividend and share consolidation
5th Apr 20224:00 pmRNSHolding(s) in Company
4th Apr 20224:00 pmRNSDirector/PDMR Shareholding
1st Apr 20222:15 pmRNSDisposal completion
1st Apr 20222:00 pmRNSTotal Voting Rights
31st Mar 20227:00 amRNSAcquisition
24th Mar 20222:00 pmRNSHolding(s) in Company
24th Mar 202211:00 amRNSDirectorate Change
21st Mar 20222:00 pmRNSHolding(s) in Company
18th Mar 20223:30 pmRNSHolding(s) in Company
10th Mar 20222:00 pmRNSHolding(s) in Company
9th Mar 20222:00 pmRNSHolding(s) in Company
1st Mar 20229:22 amRNSTotal Voting Rights
18th Feb 20222:00 pmRNSHolding(s) in Company
17th Feb 20222:00 pmRNSHolding(s) in Company
14th Feb 20222:00 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSTrading Statement
10th Feb 20222:00 pmRNSHolding(s) in Company
9th Feb 20227:00 amRNSDirectorate Change
3rd Feb 20224:00 pmRNSHolding(s) in Company
1st Feb 20223:30 pmRNSHolding(s) in Company
21st Jan 20222:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.